Cholesterol-modified Hydroxychloroquine-loaded Nanocarriers in Bleomycin-induced Pulmonary Fibrosis

An increasing number of reports have suggested the use of hydroxychloroquine (HCQ) as an adjunct anti-cancer treatment to enhance the chemotherapeutic response, as well as for the treatment of several fibrotic skin diseases and cystic fibrosis. In this study, we synthesized a cholesterol-modified HC...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Liu, Li, Ren, Jun, He, Zhiyao, Men, Ke, Mao, Ye, Ye, Tinghong, Chen, Hua, Li, Ling, Xu, Bocheng, Wei, Yuquan, Wei, Xiawei
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2017
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587549/
https://ncbi.nlm.nih.gov/pubmed/28878315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-11450-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge